文献速递神经CTMR

影像阴性(MR阴性)库欣病:呼吁标准化术语并指导影像确定性传达

Image Negative (MR negative) Cushing Disease: A Call to Standardize the Term and Guide to Convey Imaging Certainty.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-08-11

该研究针对MR表现不确定的库欣病患者,由三名神经放射学家独立盲法阅片定位垂体腺瘤,发现阅片者间一致性仅为一般(平均加权κ=0.22),所有阅片者均认为报告中有必要包含确定性传达系统。作者建议标准化「MR阴性」术语并建立影像确定性沟通框架,以指导手术规划。

要点

  • MR对库欣病垂体微腺瘤的定位判读一致性可能较低,报告时应传达诊断确定性。
  • 建议标准化「MR阴性」术语,避免将不确定信号异常过度判定为明确肿瘤。
  • 影像确定性分级有助于提示临床是否需要更广泛探查或补充影像。

核心结论

  • 库欣病垂体微腺瘤的MR判读本身存在困难,阅片者间变异可能影响病灶定位印象并进而影响手术或放疗规划。
  • 传达诊断确定性水平有助于提醒治疗医生何时需要更广泛探查或补充影像以改善治疗结局。

研究设计与样本

  • 回顾性队列研究,纳入14例经动态光子计数CTA识别、手术证实的肿瘤且MR表现不确定的患者。
  • 所有MRI由三名委员会认证的神经放射学家在不知真实腺瘤位置的情况下独立盲法审阅,要求指出最可能的腺瘤位置及置信度。

诊断标准与关键数值

  • MRI判读的阅片者间一致性总体为一般(平均加权κ=0.22)。
  • 两名阅片者之间为中等一致(κ=0.48),第三名阅片者仅轻微一致(κ=0.06-0.11)。
  • 所有神经放射学家(100%)同意在MR报告中纳入传达确定性的系统会有帮助。

临床应用与阅片要点

  • 报告垂体MR时,若病灶不确定,应明确描述信号异常及判读置信度,避免将不确定发现直接报告为明确腺瘤。
  • 对MR阴性或不确定的库欣病患者,影像确定性信息可提示临床考虑更广泛探查或补充影像。

局限性

  • 样本量小(14例),为回顾性设计。
  • 仅纳入MR表现不确定且经动态光子计数CTA识别、手术证实的病例,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Magnetic resonance imaging (MRI) is central to tumor localization in Cushing disease (CD), and patients with clearly visualized pituitary adenomas experience superior surgical outcomes compared to those with MRI-negative or equivocal disease. With continued advances in MR acquisition and post-processing, subtle signal abnormalities may be increasingly labeled as definite tumors rather than acknowledged as uncertain findings, potentially increasing the risk of inaccurate localization and unnecessary exploration. In this study, we aimed to illustrate this diagnostic challenge and propose a standardized framework for communicating MR imaging confidence to better guide surgical planning and multidisciplinary decision-making.

METHODS: We conducted a retrospective cohort study of 14 patients with operatively confirmed tumors identified by dynamic photon-counting CTA who had indeterminate MR findings. All MRI cases were independently reviewed by three board-certified neuroradiologists who were blinded to the true location of the adenomas and asked to identify, from the MRIs, where the pituitary adenomas were most likely located and with what confidence. The goal of this exercise was to understand what variance and certainty exist in difficult cases, MR indeterminate cases.

RESULTS: Interrater agreement for MRI interpretations was overall fair (mean weighted κ = 0.22), with moderate agreement between two readers (κ = 0.48) but only slight agreement involving the third reader (κ = 0.06-0.11), demonstrating poor concordance even among highly experienced neuroradiologists. All neuroradiologists agreed (100%) that a system to convey certainty would be helpful to include in the MR report.

CONCLUSIONS: Interpretation of MR imaging for pituitary microadenomas in CD can be inherently difficult, and the resulting interrater variability may contribute to differing impressions of lesion location. These discrepancies can, in turn, affect surgical or radiation planning. Communicating the level of diagnostic confidence may help alert treating clinicians when broader exploration or additional imaging could improve treatment outcomes.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Van Gompel JJ, Shinya Y, Palit S, et al. Image Negative (MR negative) Cushing Disease: A Call to Standardize the Term and Guide to Convey Imaging Certainty. AJNR Am J Neuroradiol. 2026. PMID: 42580863. doi:10.3174/ajnr.A9579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。